Epigral Limited
Cash Flow

Last updated:

Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Epigral Limited generated cash of $3,976,400,000, which is less than the previous year. Cash used in financing activities reached the amount of -$75,982,000 last year. Net change in cash is therefore -$110,570,000.

Cash Flow

Epigral Limited (NSE:EPIGRAL.NS): Cash Flow
2018 2.24B -1.66B -583.18M
2020 1.64B -3.63B 694.06M
2021 2.29B -1.96B -318.99M
2023 6.26B -4.37B -1.99B
2024 3.97B -4.01B -75.98M

EPIGRAL.NS Cash Flow Statement (2017 – 2023)

2023 2022 2020 2019 2017
Cash at beginning of period
142.4M250.85M969K1.29B856K
Operating activities
Net income
2.90B5.22B1.60B1.40B1.95B
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization
1.23B1.08B735.44M443.02M552.71M
Stock-based compensation expense
00000
Deferred income tax benefit 00000
Changes in operating assets and liabilities:
Accounts receivable, net
-121.28M904.18M-424.00M11.63M0
Inventories
-511.64M-576.89M-55.56M-77.49M-14.48M
Accounts payable
553.25M224.06M259.67M90.04M0
Cash generated by operating activities
3.97B6.26B2.29B1.64B2.24B
Investing activities
Purchases Of Investments
0-2.05M-604K-460M-1.41B
Investments In Property Plant And Equipment
-3.98B-4.16B-1.96B-3.69B-1.23B
Acquisitions Net
0-205.40M455K40.61M12.12M
Cash generated by investing activities
-4.01B-4.37B-1.96B-3.63B-1.66B
Financing activities
Common Stock Issued
0244.52M000
Payments for dividends
-251.19M-242.24M0-203.42M0
Repurchases of common stock
-550M-609.19M000
Repayments of term debt
1.45B-1.13B-872.03M1.08B-676.45M
Cash used in financing activities
-75.98M-1.99B-318.99M694.06M-583.18M
Net Change In Cash
-110.57M-108.45M5.83M-1.29B-125K
Cash at end of period
31.83M142.4M6.8M969K731K
Data sourceData sourceData sourceData sourceData source